Back

Tricuspid regurgitation peak velocity reflects structural and diastolic severity but not survival in cardiac amyloidosis

10 May 2026 (16:12 - 17:30)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease (4) Cardiac Amyloidosis HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Manel EL BLIDI

Hopital Bicetre, Le Kremlin-Bicetre (France)

6 More presentations in this session

Presentation thumbnail
Genotype and left ventricular reverse remodelling in familial dilated cardiomyopathy with contemporary heart failure therapy - the ReaGEN study
Mr P. Mangas Palma (Porto, PT)
Abstract Slides
Presentation thumbnail
Serum transthyretin decline: an early warning signal for heart failure in hATTR-CM
Doctor J. AGOSTINHO (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Unmasking hereditary transthyretin amyloidosis in Mexico: lessons from active field screening in a high-prevalence region. First interim analysis
Miss G. Martinez Gonzalez (MX)
Abstract Slides
Presentation thumbnail
Shifting paradigms in amyloidosis: transition to non-invasive diagnostics and cardiovascular characterization. A 17-year real-world experience
Doctor V. Flores (Ciudad De Mexico, MX)
Abstract Slides
Presentation thumbnail
Real world prognostic modelling and trial simulations to inform phase 3 design amid improved standard of care in ATTR-CM
Professor O. Lairez (Toulouse, FR)
Abstract Slides

Access the full session

Session thumbnail
ePosters in myocardial disease (4)

The Event

Event poster

Heart Failure 2026

10 May 2026 16:12 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources